Our ambition
Supporting customers by delivering innovative, safe, and high-quality pharmaceutical ingredients, helping them contribute to a healthier society.
We aim to leverage our rich legacy of over 70 years in the field to drive product continuity and enhance sustainability in our quest to develop new drugs that address previously unmet medical needs.
This effort is spearheaded by our commitment to investing in leading-edge research and innovation in biliary acid.
Our targets
- Continue the existing medicine donation initiative in Italy through ‘Banco Farmaceutico’ to fight pharmaceutical poverty.
- Initiate an ‘Access to Medicines Program’ to donate identified medicines to public institutions, charities, non-profits in low-income countries where ICE Pharma has an operational footprint to support communities.
- Commit to at least 60% of our R&D investments to initiatives that drive product continuity and sustainability each year, including alternative ingredients and processes with a lower environmental impact
